| scholarly article | Q13442814 |
| P2093 | author name string | J K Willson | |
| S D Markowitz | |||
| J Jackson | |||
| T Stellato | |||
| C Gerbic | |||
| K Molkentin | |||
| P2860 | cites work | Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth | Q24295049 |
| A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
| Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization | Q28115244 | ||
| Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas | Q28269089 | ||
| Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells | Q29616544 | ||
| Receptors for epidermal growth factor and other polypeptide mitogens | Q34163558 | ||
| Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells | Q34297021 | ||
| Transcriptional activation and DNase I hypersensitive sites are associated with selective expression of the gastrin-releasing peptide gene | Q34561684 | ||
| Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma | Q34579987 | ||
| Growth factors from murine sarcoma virus-transformed cells | Q37593227 | ||
| Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody | Q37605237 | ||
| Transforming growth factor alpha | Q39517957 | ||
| Elevated production of growth factor by human premalignant colon adenomas and a derived epithelial cell line | Q41144947 | ||
| Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model | Q41344835 | ||
| Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats | Q42048382 | ||
| Tissue culture of human epithelial cells from benign colonic tumors | Q42826737 | ||
| Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation | Q44691787 | ||
| Modulation of a high molecular weight form of transforming growth factor-alpha in human colon carcinoma cell lines | Q47181765 | ||
| Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. | Q48399275 | ||
| Cell culture of human colon adenomas and carcinomas. | Q53437906 | ||
| Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. | Q53514425 | ||
| Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. | Q53531416 | ||
| Autocrine secretion and malignant transformation of cells. | Q53575149 | ||
| Production and auto-induction of transforming growth factor-α in human keratinocytes | Q59048981 | ||
| Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells | Q59070965 | ||
| Prevalence of ras gene mutations in human colorectal cancers | Q59088716 | ||
| Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer | Q68024904 | ||
| Induction of transforming growth factor-alpha in activated human alveolar macrophages | Q68092790 | ||
| Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors | Q68748541 | ||
| Increased expression of the epidermal growth factor receptor on human colon carcinoma cells | Q68915071 | ||
| Growth factor production by human colon carcinoma cell lines | Q69348554 | ||
| Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract | Q69963891 | ||
| Production of transforming growth factors by human colon cancer lines | Q70121997 | ||
| Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase acti | Q70218958 | ||
| Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors | Q72403213 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 356-362 | |
| P577 | publication date | 1990-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium | |
| P478 | volume | 86 |
| Q30449276 | A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene |
| Q32069541 | Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells |
| Q43095582 | Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon |
| Q34212131 | Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin |
| Q41609616 | Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon |
| Q33559452 | Autocrine growth factors and solid tumor malignancy. |
| Q41253129 | Autocrine growth stimulation of SW403 colon carcinoma cell line is caused by transforming-growth-factor-alpha-mediated epidermal growth factor receptor activation |
| Q43854610 | Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells |
| Q53429145 | Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states. |
| Q35123003 | Biology of colorectal liver metastases |
| Q37871559 | Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. |
| Q33818072 | Cell surface molecules and their prognostic values in assessing colorectal carcinomas |
| Q34568144 | Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. |
| Q73694697 | Defective cleavage of membrane bound TGFalpha leads to enhanced activation of the EGF receptor in malignant cells |
| Q52212711 | Developmental expression of transforming growth factor-alpha and epidermal growth factor receptor proteins in the human pancreas and digestive tract. |
| Q28610061 | Differential expression of epidermal growth factor-related proteins in human colorectal tumors |
| Q24319040 | Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family |
| Q73715613 | Epidermal growth factor and insulin-like growth factor I upregulate the expression of the epidermal growth factor system in rat liver |
| Q37250403 | Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis |
| Q53477178 | Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue. |
| Q40902970 | Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. |
| Q38471203 | Expression of metastasis-related genes in surgical specimens of human gastric cancer can predict disease recurrence |
| Q40849345 | Gastrointestinal hormone mRNA expression in human colonic adenocarcinomas, hepatic metastases and cell lines |
| Q40609488 | Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines |
| Q35993625 | Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha |
| Q40958587 | Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells |
| Q40621757 | Gut hormones, growth and malignancy |
| Q67937855 | Immunohistochemical Demonstration of Epidermal Growth Factor Receptor and Ceruloplasmin in Thyroid Diseases |
| Q74420118 | Immunoreactive epidermal growth factor receptors are present in gastrointestinal epithelial cells of preterm infants with necrotising enterocolitis |
| Q34687889 | In vitro models for the identification and characterization of tumor-promoting and protective factors for colon carcinogenesis |
| Q73135954 | Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis |
| Q35816926 | Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor |
| Q33958678 | Jeremiah Metzger Lecture. Targeted cancer therapy |
| Q36734908 | Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model |
| Q41121039 | Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment |
| Q33839168 | Molecular determinants of colon cancer metastasis |
| Q54998256 | Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma. |
| Q35782463 | Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma |
| Q38485203 | Paracrine growth regulation of human colon carcinoma organ-specific metastasis |
| Q58183728 | Raf-1 kinase, epidermal growth factor receptors, and mutant ras proteins in colonic carcinomas |
| Q33996729 | Regulation of transforming growth factor alpha expression in a growth factor-independent cell line |
| Q39819174 | Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation |
| Q73943054 | Role of heparin-binding EGF-related peptides in proliferation and apoptosis of activated ras-stimulated intestinal epithelial cells |
| Q35242603 | Roles for transforming growth factor-alpha in gastric physiology and pathophysiology |
| Q33397653 | TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma |
| Q35469548 | The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells |
| Q34293543 | The EGF receptor family as targets for cancer therapy |
| Q38318597 | The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element |
| Q40665426 | The epidermal growth factor receptor as a target for therapy in breast carcinoma |
| Q37725469 | The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker |
| Q41530670 | The role of growth regulatory aberrations in progression of human colon carcinoma |
| Q34410059 | Transforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats |
| Q61902295 | Transforming growth factor-alpha precursors in human colon carcinoma cells |
| Q35144422 | Transforming growth factors and receptor as potential modifiable pre-neoplastic biomarkers of risk for colorectal neoplasms |
Search more.